CA
NZ
UK
AU
IND
US
CVRx, Inc. (NASDAQ: CVRX) shares were weighed down after the company announced that second-quarter 2026 revenue rose 16% to $15.7 million, with U.S. Barostim sales up 21% and gross margin expanding to 87%.
BioVie Inc. (NASDAQ: BIVI) shares closed down 34% at $1.35 even after the company reported Phase 2 SUNRISE-PD data for bezisterim in early Parkinson's disease that met primary endpoints.
Replimune Group, Inc. (NASDAQ: REPL) shares closed up 9% at $12.86 after the company disclosed that the FDA has granted accelerated approval for TUDRIQEV in combination with nivolumab for the treatment of patients with unresectable advanced cutaneous melanoma following anti-PD-1 progression.
Starling Oncology (NASDAQ:STLN), formerly known as The Oncology Institute before its August 2026 rebrand, is surging today as investors continue to digest a strong second-quarter earnings report released the prior afternoon. Revenue rose 34.6% year-over-year to $161.3 million, topping the $155.3 million estimate by …
Teladoc Health (NYSE:TDOC) shares are bouncing today after an extended slide that saw the stock close near $6.68 a day earlier, extending a brutal post-earnings selloff sparked by last week's Q2 report and full-year guidance cut. The stock has traded lower for several sessions …
Tenon Medical (NASDAQ:TNON) penny stock shares are sliding today after the company announced a 1-for-35 reverse stock split of its common stock. The split will become effective at 12:01 a.m. Eastern Time on August 10, 2026, prior to the start of trading on the …
UnitedHealth Group (NYSE:UNH) is trading higher today, building on gains from last week's second-quarter beat-and-raise report. The move is being driven by broader managed care sector tailwinds, as investors respond positively to improving Medicare Advantage cost trends. The stock is also riding a broader …
If you're following Centene (NYSE:CNC) today, shares are extending their post-earnings rally, trading higher as investors continue to reward the managed-care insurer's strong second-quarter beat-and-raise reported in late July. Adjusted EPS came in at $2.51 against an $0.89 estimate, while health benefits ratio improved …
Concentra Group Holdings (NYSE:CON) is trading sharply higher today after reporting second-quarter 2026 results that topped Wall Street estimates on both the top and bottom lines. Adjusted EPS came in at $0.52, beating the $0.42 estimate by nearly 24%, while revenue reached $606 million …
GeneDx Holdings (NASDAQ:WGS) shares are climbing today as investors continue to digest strong second-quarter results reported on August 3. Exome and genome test volumes rose 32% year-over-year to 30,785, while total revenue reached $114.4 million, driving a return to positive adjusted profitability for the …
Please wait processing your request...